Steven Cohen's TDOC Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 7.72 M shares of Teladoc Health, Inc. (TDOC) worth $42.08 M, representing 0.05% of the portfolio. First purchased in 2016-Q2, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in TDOC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 3.66 M shares. Largest reduction occurred in Q1 2025, reducing 4.67 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Teladoc Health (TDOC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teladoc Health (TDOC) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +2.06 M | Add 36.39% | 7.72 M | $5.45 |
| Q4 2025 | -102,020 | Reduce 1.77% | 5.66 M | $7.00 |
| Q3 2025 | -2.08 M | Reduce 26.49% | 5.76 M | $7.73 |
| Q2 2025 | +1.33 M | Add 20.43% | 7.84 M | $8.71 |
| Q1 2025 | -4.67 M | Reduce 41.77% | 6.51 M | $7.96 |
| Q4 2024 | +2.81 M | Add 33.63% | 11.18 M | $9.09 |
| Q3 2024 | +3.06 M | Add 57.76% | 8.37 M | $9.18 |
| Q2 2024 | +3.66 M | Add 221.85% | 5.3 M | $9.78 |
| Q1 2024 | +190,721 | Add 13.09% | 1.65 M | $15.10 |
| Q4 2023 | +1.46 M | New Buy | 1.46 M | $21.55 |
| Q3 2023 | -1 | Sold Out | 0 | $0.00 |
| Q2 2023 | -16,423 | Reduce 99.99% | 1 | $25.00 |
| Q1 2023 | +16,424 | New Buy | 16,424 | $25.90 |
| Q2 2022 | -14,161 | Sold Out | 0 | $0.00 |
| Q1 2022 | +14,161 | New Buy | 14,161 | $72.10 |
| Q1 2021 | -64,700 | Sold Out | 0 | $0.00 |
| Q4 2020 | +64,400 | Add 21466.67% | 64,700 | $199.95 |
| Q3 2020 | +300 | New Buy | 300 | $220.00 |
| Q1 2020 | -199,494 | Sold Out | 0 | $0.00 |
| Q4 2019 | +199,494 | New Buy | 199,494 | $83.72 |
| Q4 2018 | -49,554 | Sold Out | 0 | $0.00 |
| Q3 2018 | -41,747 | Reduce 45.72% | 49,554 | $86.35 |
| Q2 2018 | -42,274 | Reduce 31.65% | 91,301 | $58.05 |
| Q1 2018 | -1,425 | Reduce 1.06% | 133,575 | $40.30 |
| Q4 2017 | +135,000 | New Buy | 135,000 | $34.85 |
| Q1 2017 | -119,300 | Sold Out | 0 | $0.00 |
| Q4 2016 | +119,300 | New Buy | 119,300 | $16.50 |
| Q3 2016 | -104,000 | Sold Out | 0 | $0.00 |
| Q2 2016 | +104,000 | New Buy | 104,000 | $16.02 |
Steven Cohen's Teladoc Health Investment FAQs
Steven Cohen first purchased Teladoc Health, Inc. (TDOC) in Q2 2016, acquiring 104,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Teladoc Health, Inc. (TDOC) for 29 quarters since Q2 2016.
Steven Cohen's largest addition to Teladoc Health, Inc. (TDOC) was in Q2 2024, adding 5,303,123 shares worth $51.86 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 7,721,495 shares of Teladoc Health, Inc. (TDOC), valued at approximately $42.08 M.
As of the Q1 2026 filing, Teladoc Health, Inc. (TDOC) represents approximately 0.05% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Teladoc Health, Inc. (TDOC) was 11,179,863 shares, as reported at the end of Q4 2024.